Spending power
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Brand profile · Biotechnology Research
Anatara Lifesciences Ltd works in Biotechnology Research, out of Adelaide, South Australia. Ownership is publicly held; it publishes at anataralifesciences.com. It holds one address on record, all in Australia. The record counts 7 people. One Australian registration (ABN) is a confirmed match. The record links seven similar brands, most of them in Biotechnology Research.
anataralifesciences.com LinkedIn
ABN41145239872
| ANATARA LIFESCIENCES LTD | ABN 41145239872 |
|---|---|
| Confirmed matches | 0 of 1 |
A candidate is a name match on the registry, not a confirmed identity, and two candidates are ambiguity rather than a corporate structure.
Anatara Lifesciences is developing evidence-based solutions for gastrointestinal diseases in humans and animals.
GaRP is the working name for Anatara’s evidence based complementary medicines using unique formulations of bromelain, an enzyme extracted from pineapple stems along with other synergistic GRAS components. The combination and coating of these GaRP components have a beneficial effect on the physiology of the gastrointestinal lining, a positive influence on the microbiome (homeostasis & metabolites) and allows absorption of components in targeted areas of the gastrointestinal tract. GaRP’s multimodal activity provides a versatility for tailoring the components to various indications.
Human Applications
GaRP's human formulation is a microbiome-targeted multi-component complementary medicine that has been designed to address the primary underlying factors associated with gastrointestinal disorders such as IBS and IBD. Our formulation is positioned as an adjunct to existing therapies and is currently being tested in a double-blinded, placebo-controlled human clinical trial for safety and efficacy.
For further information on our human development plans, visit our webpage: https://anataralifesciences.com/products-pipeline/human-applications/.
Animal Applications
Anatara developed Detach® for the control of scour (diarrhoea) in pigs which was approved the Australian Pesticides and Veterinary Medicines Authority (APVMA). Detach® has been shown to reduce post-weaning diarrhoea and provide similar protection to antimicrobial agents, such as zinc oxide.
BONIFF is a revised formulation of Detach® that can be applied to dry feed for piglets after weaning for a simplified feeding process.
ANR-pf is a proprietary enriched formulation for poultry in water, providing a quick and flexible dosing method on-farm.
For further information on our Detach® development plans, visit our webpage: https://anataralifesciences.com/products-pipeline/animal-applications/.
| Countries | 1 |
|---|---|
| Primary country | AU |
All codes: AU
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Hiring, headcount and registry-change signals, streamed to members.
Registry-filed capital and financial indicators, standardised by TheGrid.
4 employee profiles on record · names withheld.
Names and titles are intentionally absent from this page. The source relation carries no consent record across the privacy regimes this directory spans, so it is never requested and never stored. Search engines see exactly what you see here.
Counts only. No names are stored here, and none are served.
One South Australia entity on the ABR. ANATARA LIFESCIENCES LTD (ABN 41 145 239 872), high confidence.
The record holds 7 counted staff profiles at January 2026, inside the self-reported 2–10 band.
One address on record, Australia only. Primary: 81 Flinders St, Adelaide, South Australia 5000.
None linked to this brand.
5 profiles list Anatara Lifesciences Ltd as a peer — 62nd percentile in Biotechnology Research. It lists ten peers of its own. ANTARASIA MEDTECH SDN. BHD and Immuron list it back.